STAT Plus: Pharmalittle: Buttigieg wants pharma to ‘thrive’; U.S. patent panel boosts Biogen, disappoints Gilead

Pete Buttigieg has said he wants drug companies to “thrive," but thriving under a Buttigieg administration would not be business as usual.

Click to view original post